Concepedia

Publication | Open Access

A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species

DOIFull Paper Access

71

Citations

32

References

2021

Year

Guoju Hong, Zhenqiu Chen, Xiaorui Han, Lin Zhou, Fengxiang Pang, Rishana Wu, Ying-Shan Shen, Xiaoming He, Zhinan Hong, Ziqi Li,
Clinical and Translational Medicine

Abstract

Rob inhibits the activation of osteoclasts by targeting RANKL and is therefore a potential osteoporosis drug.

References

YearCitations

Page 1